Neonatal desensitisation edit.pdf (418.7 kB)
Download file

Neonatal desensitisation for the study of regenerative medicine

Download (418.7 kB)
journal contribution
posted on 25.03.2022, 16:06 authored by Victoria H. Roberton, Anne E. Rosser, Claire KellyClaire Kelly
Cell replacement is a therapeutic option for numerous diseases of the CNS. Current research has identified a number of potential human donor cell types, for which preclinical testing through xenotransplantation in animal models is imperative. Immune modulation is necessary to promote donor cell survival for sufficient time to assess safety and efficacy. Neonatal desensitization can promote survival of human donor cells in adult rat hosts with little impact on the health of the host and for substantially longer than conventional methods, and has subsequently been applied in a range of studies with variable outcomes. Reviewing these findings may provide insight into the method and its potential for use in preclinical studies in regenerative medicine

History

Published in

Regenerative Medicine

Publisher

Future Medicine

Version

AM (Accepted Manuscript)

Citation

Roberton, V.H., Rosser, A.E. and Kelly, C.M. (2015) 'Neonatal desensitization for the study of regenerative medicine', Regenerative medicine, 10(3), pp.265-274

Print ISSN

1746-0751

Electronic ISSN

1746-076X

Cardiff Met Affiliation

  • Cardiff School of Sport and Health Sciences

Cardiff Met Authors

Claire Kelly

Cardiff Met Research Centre/Group

  • Cellular Senescence and Pathophysiology

Copyright Holder

© The Publisher

Language

en